P2RY12 and myocardial infarction: As before, prasugrel treatment still reduced LSK cycling in the bone marrow and leukocyte numbers in circulation and the infarcted myocardium in the acute phase after MI, indicating a significant role of P2Y12 signaling in inflammation beyond platelet-induced immunoregulation.